REFERENCES
- Mruthyunjaya P. Central Retinal Vein Occlusion, S. Ryan, Ed. 2009, Elsevier.
- The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114(5):545–54.
- Leoncini G, Bruzzese D, Signorello MG, et al. Platelet activation by collagen is increased in retinal vein occlusion. Thromb Haemost. 2007;97(2):218–27.
- Fong AC, Schatz H, McDonald HR, et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina. 1992;12(1):3–11.
- Kratz A, Wood MJ, Siegel AJ, Hiers JR, Van Cott EM. Effects of marathon running on platelet activation markers: direct evidence for in vivo platelet activation. Am J Clin Pathol. 2006;125(2):296–300.
- Clarkson PM. Exertional rhabdomyolysis and acute renal failure in marathon runners. Sports Med. 2007;37(4–5):361–3.
- Wallen NH, Goodall AH, Li N, et al. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond). 1999;97(1):27–35.
- Gale J, Wells AP, Wilson G. Effects of exercise on ocular physiology and disease. Surv Ophthalmol. 2009;54(3):349–55.
- Remky A, et al. Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefes Arch Clin Exp Ophthalmol. 1996;234(Suppl 1):S8–12.
- Li N, He SM., Blomback M, Hjemdahl P. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Arterioscler Thromb Vasc Biol. 2007;27(2):407–13.
- Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets. 2008;19(2):115–18.
- Bae SH, Lee J, Roh KH, et al. Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol. 2003;17(2):140–4.
- Yazici M, A Kaya, Y Kaya, et al. Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets. 2009;20(1):58–63.
- van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921.
- Faude F, Faude S, Siegemund A, et al. Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group. Klin Monatsbl Augenheilkd. 2004;221(10):862–6.
- Dimitriadou C, Dessypris A, Louizou C, et al. Marathon run II: Effects on platelet aggregation. Thromb Haemost. 1977;37(3):451–5.
- Disdier P, Harle R, Swiader L, et al. Retinal vein occlusions in a marathon runner. Presse Med. 1992;21(12):582.
- Rocker L,Drygas WK, Heyduck B. Blood platelet activation and increase in thrombin activity following a marathon race. Eur J Appl Physiol Occup Physiol. 1986;55(4):374–80.
- Jampol LM, Fleischman JA. Central retinal-vein occlusion five days after a marathon. N Engl J Med. 1981;305(13):764.